By Grant J. Anhalt, M.D. and Hossein Nousari, M.D.Johns Hopkins University, School of Medicine In February 1997, the FDA approved a new drug, mycophenolate mofetil (MFM, also known as Cellcept) with an approved indication for use in immunosuppression of patients…
- Inicio
- Sobre nosotros
- Viviendo con P/P
- Investigación
- Involucrarse
- Noticias & Info
- Discussion Forums
